4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-030256
Chief Executive Officer sold 15,502 shares at an average $3.20 ($49,620)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2023-06-27 | Sale | −7,086 | $3.19 | $22,604 | 631,873 | D |
| Barrow Robert Chief Executive Officer | 2023-06-27 | Sale | −8,416 | $3.21 | $27,015 | 623,457 | D |
| Open-market sales · 15,502 sh · avg $3.20 · $49,620 | |||||||
Loading xslF345X04/ownership.xml…